<code id='DCBA94E94C'></code><style id='DCBA94E94C'></style>
    • <acronym id='DCBA94E94C'></acronym>
      <center id='DCBA94E94C'><center id='DCBA94E94C'><tfoot id='DCBA94E94C'></tfoot></center><abbr id='DCBA94E94C'><dir id='DCBA94E94C'><tfoot id='DCBA94E94C'></tfoot><noframes id='DCBA94E94C'>

    • <optgroup id='DCBA94E94C'><strike id='DCBA94E94C'><sup id='DCBA94E94C'></sup></strike><code id='DCBA94E94C'></code></optgroup>
        1. <b id='DCBA94E94C'><label id='DCBA94E94C'><select id='DCBA94E94C'><dt id='DCBA94E94C'><span id='DCBA94E94C'></span></dt></select></label></b><u id='DCBA94E94C'></u>
          <i id='DCBA94E94C'><strike id='DCBA94E94C'><tt id='DCBA94E94C'><pre id='DCBA94E94C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:7
          Mike Belleme for STAT

          Five years after investor-owned HCA Healthcare took over an esteemed nonprofit hospital in North Carolina, Medicare is threatening to cut off payment for any services it provides seniors.

          The rare and dramatic move follows a Medicare revelation that patient safety is in “immediate jeopardy” at Mission Hospital in Asheville. That designation is the most severe the agency can hand out. HCA has just a few weeks to fix the problems or lose its Medicare funding.

          advertisement

          “If on average Medicare pays roughly one-third of your revenue, if they stop paying you, you will die,” said Michael Millenson, a national patient safety expert and president of the consultancy Health Quality Advisors. “That’s why it gets immediate attention from the hospital management, because it’s a death threat.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

          YichuanCao/SipaUSAGileadSciencessaidMondayitwillacquireCymaBayTherapeuticsfor$4.3billion,addinganewt

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          How digital tools helped lower hypertension in marginalized patients

          Digitaltoolstobettertrackbloodpressureovertimeandencourageadherencetotreatmentplansareincreasinglyco